???????? ???????????????? ????????????: BaseCure Therapeutics is a Delaware area startup that is working on siRNAs for cardiometabolic diseases like hypertension and obesity. Acting CEO Jing Yang says the company's obesity approach will try to avoid the muscle wasting that comes with GLPs by focusing on the fat cells. They could be in the clinic sometime early next year. Full video: https://lnkd.in/gEDCUePG BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
BaseCure Therapeutics
制药业
Strives to become a world leader in delivering the next generation RNAi medicines
关于我们
BaseCure strives to become a world leader in delivering the next generation RNAi medicines
- 所属行业
- 制药业
- 规模
- 2-10 人
- 类型
- 合营企业
- 创立
- 2022
- 领域
- SiRNA